$ 0.000 0.04%
Encrypgen (DNA) Rank 2158
Ecrypgen provides next generation software for securely storing, sharing, and protecting genomic data through the use of Gene-Chain, a private blockchain database create for the sole purpose of storing genomic data. The sole currency for transactions within the Gene-Chain (among those who wish to share information) will be DNA token.
| Mkt.Cap | $ 0.00000000 | Volume 24H | 0.00000000DNA |
| Market share | 0% | Total Supply | 100 MDNA |
| Proof type | Open | $ 0.00000070 | |
| Low | $ 0.00000070 | High | $ 0.00000070 |
Encrypgen. All about cryptocurrency
The sole currency for transactions within the Gene-Chain (among those who wish to share information) will be DNA token. EncrypGen's Gene-Chain DNA Data Marketplace brings DNA data owners together with DNA data buyers.
Not even a blockchain can prevent that from happening. So you still have to be careful about whom you trust with your DNA. Potential buyers can search for data by self-reported health conditions or by physical characteristics, such as body-mass index, ethnic background, or age.
In the last three years, nearly 150 companies building biomedical blockchain applications have raised more than $660 million in the private and cryptocurrency markets. This offer comes bundled with all the promises of security, anonymity, and transparency (and money!) at the core of the blockchain’s immutable ledger. Once users have their genome sequenced, they can charge a fee, in tokens, to anyone who wants to access it. In the future, those tokens can be redeemed for additional tests and products that will further interpret your DNA.
Today EncrypGen price in US dollars is currently 0.0162 USD, and if converted to Bitcoin is 0. A total of 118 coin's are currently circulating in the Market. EncrypGen prices are currently experiencing a change of 5.05 %, check all cryptocurrency. Over the past 24 hours 0.000 M US dollars EncrypGen has been traded on Crypto Exchanges.
Another possibility is that researchers will bypass the company and just go directly to the exchanges to buy tokens. Either way, it’s clear that Encrypgen has reached the point of utility and traders can begin to expect a significant run-up in the token price. Please don't discuss price speculation or trading on the main discord channel as they are maintaining its status as a utility token and must avoid such discussion on official channels. Users also retain more control over their data than is typical. Anyone who’s been granted access to an individual’s de-identified DNA can only crunch analyses on that data using Nebula’s own computers.
Nebula is joining another genomic data platform, called EncrypGen, which launched the first blockchain-enabled DNA marketplace on November 6. Called Gene-Chain, it allows users to upload the kind of genetic data produced by most direct-to-consumer companies, including 23andMe and Ancestry, and set a price for potential buyers. David Koepsell, the company’s CEO, says it is aiming to attract the 20 percent of 23andMe customers who’ve decided against participating in the testing company’s research program. Encrypgen plans to support whole genome sequences by the end of the year.
If you don’t want to answer survey questions about your donut and negroni habits or your family’s history of heart disease, you can get the same quick-and-dirty sequence for $99. But if you do answer the questions, and if a researcher or pharmaceutical company finds them interesting, they might pay to upgrade you to the Cadillac of whole genomes (what’s called 30x coverage, in the gene biz). In exchange, you grant them permission to study your data. Two different marketplaces for genetic data, Nebula and EncrypGen, recently launched with the promise of better protections for their users.
80% of the total 100 million DNA supply will be available. 10% will go to the founding team, 5% will be reserved for bonuses while another 5% will be used for marketing by the company. Users can invest with Bitcoin, Ether, Ether Classic, Litecoin and Dash.
As mentioned earlier, Encrypgen has now launched the world’s first genomic data marketplace. So, while there are some competitors, they are years behind.
Gene-Chain offers blockchain enhanced security for safe cloud storage and sharing of genomic data. Clear Gene is a molecular diagnostics company that combines machine learning and genomics to detect residual solid tumor after cancer treatment in order to reduce unnecessary treatments. EncrypGen is a blockchain project designed to allow individuals to place their genetic code on the blockchain privately and securely and manage the ability to sell it to researchers. Using the blockchain to do so is an enticing idea, and Nebula is far from alone.
Tweet with a location
DNA tokens used to buy any data can be converted to bitcoin or ethereum on a cryptocurrency exchange. EncrypGen provides next generation software for securely storing, sharing, and protecting genomic data through the use of Gene-Chain, a private blockchain database create for the sole purpose of storing genomic data.
Back in August, Encrypgen launched the beta version of its Gene-Chain. And now today, Encrypgen will officially launch version 1 of the world’s first blockchain genomic data marketplace. Encrypgen is a fairly new corporation whose intent is to provide the infrastructure to transfer genomic data between individuals, researches, and any party with interest in accessing genomic data. The unique features of the infrastructure they are creating is that it is secure and provides ownership/ control to the individuals that upload their genomic data. They are able to provide these features through the use of proprietary blockchain technology that they have created.
Bitcoin Ready For Massive Price Reversal
DNA data is bought and sold with DNA Tokens on the blockchain. Co-founded in 2016 by George Church, one of the field’s OGs (that’s Original Genomicist to you), Nebula is one of a collection of companies trying to speed up the arrival of personalized medicine. Its subsidized 30X whole-genome sequencing services will be provided primarily by nearby Veritas, another Church-founded startup. Together, they want to help people see the value in every bit of their double helix. DNA can be big business, as genetic testing company 23andMe recently made plain with its blockbuster $300 million pharma deal.
Get EncrypGen's progress by adding it to your favourites and creating a free portfolio if you wish. The big secret of genetic testing is that most big testing companies make much of their money reselling your data.
- In a nutshell, that means that the value of the token will be determined by real-world usage.
- The sole currency for transactions within the Gene-Chain (among those who wish to share information) will be DNA token.
- EncrypGen will revolutionize the sharing of genetic data between scientists, labs, and citizens.
- In the last three years, nearly 150 companies building biomedical blockchain applications have raised more than $660 million in the private and cryptocurrency markets.
- The DNA Initial Coin Offering started on the first of June at midnight UTC and will last until the 18th of July or until the 1000 BTC hardcap is reached, whichever happens first.
The applications that utilize this blockchain are currently under development. As with all blockchains, it requires the use of a token and that token is the $DNA token. This token will be the monopoly currency of the "gene-chain" network. Thus far it looks as though one or several partners of Encrypgen are interested in using the DNA token for their own genomics applications. EncrypGen provides next-generation software for securely storing, sharing, and protecting genomic data through the use of Gene-Chain, a private blockchain database create for the sole purpose of storing genomic data.
EncrypGen (DNA)
The website provides a list of cryptocurrency and bloclchain related events, valid and authentic list of cryptocurrency wallets and Bitcoin mining pools. We also provide rich advertisement campaings to advertise your bussiness on this website. The DNA Initial Coin Offering started on the first of June at midnight UTC and will last until the 18th of July or until the 1000 BTC hardcap is reached, whichever happens first.
Encrypgen is certainly the undisputed leader of blockchain genomics at this point. Market Overview Watch updated crypto prices, market caps, volumes.
Crypto investors have had an extremely rough year. Losses have been massive and it’s unclear when the bear market will end. One of the biggest reasons behind the precipitous drop in token prices has been due to companies not achieving what they promised. One company that is bucking that trend is Encrypgen (DNA).
Explore additional financial information, social presence, online presence, team behind Encrypgen (DNA) project, marketing possibilities and more, as it grows and expands. Federal policies for protecting human research subjects do not currently extend to de-identified genetic data. But those laws have come under increasing scrutiny as DNA data combined with information from other databases has exposed individuals’ identities. “Once you give access to your genome data, there’s no magical self-destruct button,” says Zimmerman.
Your data should be private, under your control, and of value to you. As traders can see, these 3 competitors above certainly should be acknowledged but there doesn’t appear to be much cause for concern.
Encrypgen (DNA) ICO Details & Financial Information
Marketplaces like Nebula will allow individuals to cash in on the genomics rush themselves while retaining control over who gets to profit from their data. Track and analyze Encrypgen (DNA) ICO information, market data, whitepaper, token price. Get involved with Encrypgen (DNA) Initial Coin Offering (ICO) movement, ratings, roadmap. Use 48coins ICO Tracker and Funding data to quickly analyze the Encrypgen (DNA) target sale, ICO start, ICO end, softcap, hardcap, platform used and more.
With the implementation of the buy now feature, researchers and scientists will be able to purchase DNA tokens directly on the platform. Those DNA tokens will come directly from Encrypgen’s inventory of approximately 3 million. As that supply diminishes, Encrypgen will then have to go to the exchanges, such as Cryptopia and Kucoin, to buy more tokens.
Learn the latest
On National Privacy Day, remember, if your DNA data market wants personal info so they can mail you gifts cards or distribute "shares," they aren't protecting your privacy like we do. CryptoStatZ shows the most accurate live prices, charts and market rates from trusted top crypto exchanges globally. CryptoStatZ have over 2100+ cryptocurrencies, trusted historical data, details of active, upcoming and finished ICOs.
The main competitors include LunaDNA, Nebula Genomics, and Shivom. In a nutshell, that means that the value of the token will be determined by real-world usage.
